What drugs does ALKERMES INC make?

ALKERMES INC has 4 FDA-approved drugs including LYBALVI, ARISTADA INITIO KIT, ARISTADA.

What therapeutic areas does ALKERMES INC focus on?

ALKERMES INC focuses primarily on Gastroenterology.

← Back

Data updated: Mar 10, 2026

ALKERMES INC

Gastroenterology

Specialty

ALKERMES INC is a specialty pharmaceutical company focused on Gastroenterology. Key products include LYBALVI.

2006

Since

Drugs

Trials

Approved (2yr)

Key Drugs

LYBALVI

olanzapine

CNS

5HT2 receptor 3 indications · 2021

ARISTADA INITIO KIT

aripiprazole lauroxil

CNS

5-HT1A receptor 1 indications · 2018

ARISTADA

aripiprazole lauroxil

CNS

5-HT1A receptor 1 indications · 2015

Recent Activity

ARISTADA INITIO KIT 2025-01-22

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Gastroenterology 100%

0 drugs Phase 1: 1

Pipeline Strength ProEarly access

Competitors ProEarly access

Pfizer big-pharma

Gastroenterology

Bristol-Myers Squibb big-pharma

ALKERMES INC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (4)

Active (4)

Discontinued (0)

Company Info